BDBM50393101 CHEMBL2152916::US10231967, Example 20i::US8865911, 20i::US8865911, 20i Isomer 1::US8865911, 20i Isomer 2::US9918985, Example 20i Isomer 1

SMILES CO[C@H]1CC[C@@]2(Cc3ccc(cc3C22N=C(C)C(N)=N2)C#CC2CC2)CC1

InChI Key InChIKey=ZTHSMBOBTMQWJX-SCTJWGJOSA-N

Data  12 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 50393101   

TargetBeta-secretase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  4.80nMpH: 9.2Assay Description:TR-FRET AssayThe beta-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human beta-Secretase (AA 1-AA...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetBeta-secretase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  1.45E+4nMpH: 9.2Assay Description:The beta-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human beta-Secretase (AA 1-AA 460) was clo...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetBeta-secretase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  2.20nMpH: 9.2Assay Description:TR-FRET AssayThe beta-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human beta-Secretase (AA 1-AA...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetBeta-secretase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  4.80nMAssay Description:Inhibition of BACE by TR-FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetBeta-secretase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  4.60nMAssay Description:Inhibition of BACE by secreted APPbeta release assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetBeta-secretase 1 [1-460](Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  1.45E+4nMAssay Description:The enzyme (truncated form) was diluted to 6 μg/mL (stock 1.3 mg/mL) and the substrate (Europium)CEVNLDAEFK(Qsy7) to 200 nM (stock 120 μM) ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetAmyloid-beta precursor protein(Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  4.60nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetAmyloid-beta precursor protein(Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  2.20nMAssay Description:The β-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human β-Secretase (AA 1-AA 460) was...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetAmyloid-beta precursor protein(Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  2.20nMAssay Description:The β-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human β-Secretase (AA 1-AA 460) was...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetAmyloid-beta precursor protein(Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  2.30nMAssay Description:SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at −140° C. at a ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetBeta-secretase 1 [1-460](Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  4.80nMAssay Description:The enzyme (truncated form) was diluted to 6 μg/mL (stock 1.3 mg/mL) and the substrate (Europium)CEVNLDAEFK(Qsy7) to 200 nM (stock 120 μM) ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetAmyloid-beta precursor protein(Human)
Astrazeneca

US Patent
LigandPNGBDBM50393101(CHEMBL2152916 | US10231967, Example 20i | US886591...)
Affinity DataIC50:  4.80nMAssay Description:The β-secretase enzyme used in the TR-FRET is prepared as follows: The cDNA for the soluble part of the human β-Secretase (AA 1-AA 460) was...More data for this Ligand-Target Pair
In DepthDetails US Patent